allergy treatment Market Outlook 2025-2034: Trends and Projections

What is the Market Size Analysis for the Global Allergy Immunotherapy Market?
The global allergy immunotherapy market has witnessed exponential growth over the recent years. From $2.88 billion in 2024, this market is projected to grow to $3.17 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. Factors such as increasing incidence of allergic diseases, advancements in immunotherapy techniques, growing awareness among patients, government initiatives, and improvements in research and development have contributed to this growth.

Looking forward to the next few years, the allergy immunotherapy market is expected to further expand rapidly, catapulting to $5.07 billion in 2029 at a CAGR of 12.4%. The projected growth is attributed to the rising global allergy burden, healthcare policy support, increased acceptance of immunotherapy, emerging markets and untapped regions, and increasing healthcare expenditure. Major trends observed during the forecast period include advancements in treatment technology, increasing allergy prevalence, rise in patient awareness and education, telemedicine and remote monitoring, and customized treatment plans.

Don’t miss out on enlightening market insights. Grab your free sample of the Global Allergy Immunotherapy Market Report now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

What Drives the Allergy Immunotherapy Market Growth?
The increasing prevalence of allergic disorders is a defining driver of growth in the allergy immunotherapy market. Excessive immune responses to specific antigens, often leading to autoimmune diseases, have been rampant. Allergy immunotherapy is sought after by patients with allergy disorders like IgE-mediated allergic rhinitis and allergic asthma induced by inhaled allergens, such as pollens and house dust mites (HDMs). According to the UK-based Medicines and Healthcare Products Regulatory Agency (MHRA), English hospitals registered over 25,000 admissions for allergies and anaphylaxis in 2022-23, more than double the rate over the last twenty years. Furthermore, the Food Standards Agency revealed that food allergies affect approximately 6% of adults in the UK, which is almost 2.4 million individuals.

What are the Major Segments within the Global Allergy Immunotherapy Market?
The allergy immunotherapy market is segmented based on:

1) Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types
2) Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)
3) Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Secure your copy of the exclusive report swiftly:
https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Who are the Major Players in the Allergy Immunotherapy Market?
The allergy immunotherapy market is served by key players such as LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc, among others.

What Trends are Shaping the Allergy Immunotherapy Market?
In the allergy immunotherapy market, novel trends like the adoption of artificial intelligence (AI) in allergy component testing have emerged. AI-powered allergy component testing introduces a new testing platform based on component resolved diagnostics (CRD) for diagnosing different types of allergies. Its adoption provides granular insights, aids in optimizing the course of treatment for allergic diseases, and predicts the effectiveness of immunotherapy for allergy vaccinations.

How does the Regional Analysis of the Allergy Immunotherapy Market look like?
Europe dominated the allergy immunotherapy market in 2024, while the fastest-growing region during the forecast period is projected to be Asia-Pacific. The global allergy immunotherapy market report covers regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Allergy Immunotherapy Market Report 2025 – What does it offer?
Allergy immunotherapy is a therapy employed to prevent allergic reactions to substances including house dust mites, grass pollen, and bee venom. A process where the patient is given incrementally higher dosages of the allergen they are allergic this market is poised for unprecedented growth.

Unlock expansive market insights by purchasing this exclusive report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9416

About The Business Research Company
Learn More About the Business Research Company. With over 15000+ reports spanning 27 industries and 60+ geographies, The Business Research Company has established a reputation for comprehensive, data-rich research and insights. Equipped with 1,500,000 datasets, in-depth secondary research, and unique industry leader insights, you can get the information you need to stay ahead.
The Global Market Model is our flagship product, a premier market intelligence platform delivering comprehensive and updated forecasts to facilitate informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply

Your email address will not be published. Required fields are marked *